Heart Test Laboratories, Inc. (HSCS)
- Previous Close
0.0706 - Open
0.0735 - Bid 0.0789 x 200
- Ask 0.0798 x 200
- Day's Range
0.0722 - 0.0820 - 52 Week Range
0.0680 - 1.2800 - Volume
3,039,912 - Avg. Volume
1,968,109 - Market Cap (intraday)
5.186M - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-0.3500 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.68
Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.
heartsciences.comRecent News: HSCS
Performance Overview: HSCS
Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HSCS
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HSCS
Valuation Measures
Market Cap
4.63M
Enterprise Value
-1.39M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
80.93
Price/Book (mrq)
0.54
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-52.73%
Return on Equity (ttm)
-152.61%
Revenue (ttm)
18.6k
Net Income Avi to Common (ttm)
-6.39M
Diluted EPS (ttm)
-0.3500
Balance Sheet and Cash Flow
Total Cash (mrq)
7.08M
Total Debt/Equity (mrq)
12.27%
Levered Free Cash Flow (ttm)
-4.89M
Research Analysis: HSCS
Company Insights: HSCS
HSCS does not have Company Insights